Benros, M. E. et al. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70, 812–820 (2013).
Khandaker, G. M., Dantzer, R. & Jones, P. B. Immunopsychiatry: important facts. Psychol. Med. 47, 2229–2237 (2017).
Estes, M. L. & McAllister, A. K. Maternal immune activation: Implications for neuropsychiatric disorders. Science 353, 772–777 (2016).
Yolken, R. et al. Individuals hospitalized with acute mania have increased exposure to antimicrobial medications. Bipolar Disord. 18, 404–409 (2016).
Betts, K. S., Salom, C. L., Williams, G. M., Najman, J. M. & Alati, R. Associations between self-reported symptoms of prenatal maternal infection and post-traumatic stress disorder in offspring: evidence from a prospective birth cohort study. J. Affect Disord. 175, 241–247 (2015).
Adam, Y., Meinlschmidt, G. & Lieb, R. Associations between mental disorders and the common cold in adults: a population-based cross-sectional study. J. Psychosom. Res. 74, 69–73 (2013).
Kohler-Forsberg, O. et al. A Nationwide Study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents. JAMA Psychiatry 76, 271–279 (2019).
Kohler, O. et al. Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study. Acta Psychiatr. Scand. 135, 97–105 (2017).
Mitchell, R. H. & Goldstein, B. I. Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J. Am. Acad. Child Adolesc. Psychiatry 53, 274–296 (2014).
Fung, T. C., Olson, C. A. & Hsiao, E. Y. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 20, 145–155 (2017).
Rice, D. & Barone, S. Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108, 511–533 (2000).
Blomstrom, A. et al. Associations between maternal infection during pregnancy, childhood infections, and the risk of subsequent psychotic disorder–A Swedish Cohort Study of Nearly 2 million individuals. Schizophr. Bull. 42, 125–133 (2016).
Dreier, J. W. et al. Fever and infections during pregnancy and psychosis-like experiences in the offspring at age 11. A prospective study within the Danish National Birth Cohort. Psychol. Med. 48, 426–436 (2018).
Flinkkila, E., Keski-Rahkonen, A., Marttunen, M. & Raevuori, A. Prenatal inflammation, infections and mental disorders. Psychopathology 49, 317–333 (2016).
Lydholm, C. N. et al. Parental infections before, during, and after pregnancy as risk factors for mental disorders in childhood and adolescence: A Nationwide Danish Study. Biol. Psychiatry 85, 317–325 (2019).
Slykerman, R. F. et al. Antibiotics in the first year of life and subsequent neurocognitive outcomes. Acta Paediatr. 106, 87–94 (2017).
Hamad, A. F., Alessi-Severini, S., Mahmud, S. M., Brownell, M. & Kuo, I. F. Early childhood antibiotics use and autism spectrum disorders: a population-based cohort study. Int J. Epidemiol. 47, 1497–1506 (2018).
Axelsson, P. B. et al. Investigating the effects of cesarean delivery and antibiotic use in early childhood on risk of later attention deficit hyperactivity disorder. J. Child Psychol. Psychiatry 60, 151–159 (2019).
Guida, F. et al. Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behav. Immun. 67, 230–245 (2018).
O’Mahony, S. M. et al. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 277, 885–901 (2014).
Desbonnet, L. et al. Gut microbiota depletion from early adolescence in mice: Implications for brain and behaviour. Brain Behav. Immun. 48, 165–173 (2015).
O’Mahony, S. M., Clarke, G., Dinan, T. G. & Cryan, J. F. Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle? Neuroscience 342, 37–54 (2017).
Mueller, N. T., Bakacs, E., Combellick, J., Grigoryan, Z. & Dominguez-Bello, M. G. The infant microbiome development: mom matters. Trends Mol. Med. 21, 109–117 (2015).
Clarke, G., O’Mahony, S. M., Dinan, T. G. & Cryan, J. F. Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour. Acta Paediatr. 103, 812–819 (2014).
Rodriguez, J. M. et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Micro. Ecol. Health Dis. 26, 26050 (2015).
Borre, Y. E. et al. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol. Med. 20, 509–518 (2014).
Fouhy, F. et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob. Agents Chemother. 56, 5811–5820 (2012).
Johnson, C. L. & Versalovic, J. The human microbiome and its potential importance to pediatrics. Pediatrics 129, 950–960 (2012).
Hussey, S., et al. Parenteral antibiotics reduce bifidobacteria colonization and diversity in neonates. Int. J. Microbiol. 2011, 130574 (2011).
Artama, M., Gissler, M., Malm, H. & Ritvanen, A. Drugs, Pregnancy Study G. Nationwide register-based surveillance system on drugs and pregnancy in Finland 1996–2006. Pharmacoepidemiol. Drug Saf. 20, 729–738 (2011).
Gissler, M., Teperi, J., Hemminki, E. & Merilainen, J. Data quality after restructuring a national medical registry. Scand. J. Soc. Med. 23, 75–80 (1995).
Furu, K. et al. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin. Pharm. Toxicol. 106, 86–94 (2010).
Klaukka, T. The Finnish database on drug utilization. Norwegian J. Epidemiol. 11, 19–22 (2001).
Sund, R. Quality of the finnish hospital discharge register: a systematic review. Scand. J. Public Health 40, 505–515 (2012).
Lampi, K. M. et al. Brief report: validity of Finnish registry-based diagnoses of autism with the ADI-R. Acta Paediatr. 99, 1425–1428 (2010).
Almqvist, C. et al. Individual maternal and child exposure to antibiotics in hospital – a national population-based validation study. Acta Paediatr. 104, 392–395 (2015).
Sankilampi, U., Hannila, M. L., Saari, A., Gissler, M. & Dunkel, L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann. Med. 45, 446–454 (2013).
Clayton, P. E. et al. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J. Clin. Endocrinol. Metab. 92, 804–810 (2007).
Gissler, M., Merilainen, J., Vuori, E. & Hemminki, E. Register based monitoring shows decreasing socioeconomic differences in Finnish perinatal health. J. Epidemiol. Community Health 57, 433–439 (2003).
Class, Q. A., Rickert, M. E., Larsson, H., Lichtenstein, P. & D’Onofrio, B. M. Fetal growth and psychiatric and socioeconomic problems: population-based sibling comparison. Br. J. Psychiatry 205, 355–361 (2014).
Chang, Z. et al. Maternal age at childbirth and risk for ADHD in offspring: a population-based cohort study. Int J. Epidemiol. 43, 1815–1824 (2014).
Ekblad, M., Gissler, M., Lehtonen, L. & Korkeila, J. Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood. Arch. Gen. Psychiatry 67, 841–849 (2010).
van der Burg, J. W. et al. The role of systemic inflammation linking maternal BMI to neurodevelopment in children. Pediatr. Res. 79, 3–12 (2016).
Lucas, P. J., Cabral, C., Hay, A. D. & Horwood, J. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand. J. Prim. Health Care 33, 11–20 (2015).
Dekker, A. R., Verheij, T. J. & van der Velden, A. W. Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients. Fam. Pract. 32, 401–407 (2015).
Kardas, P., Devine, S., Golembesky, A. & Roberts, C. A systematic review and meta-analysis of misuse of antibiotic therapies in the community. Int J. Antimicrob. Agents 26, 106–113 (2005).
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56 (2008).
Schwarcz, R., Bruno, J. P., Muchowski, P. J. & Wu, H. Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 13, 465–477 (2012).
Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586–597 (2016).
Braniste, V. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158 (2014).
Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965–977 (2015).
Wang, Y. et al. The intestinal microbiota regulates body composition through NFIL3 and the circadian clock. Science 357, 912–916 (2017).
Musiek, E. S. & Holtzman, D. M. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science 354, 1004–1008 (2016).
Ostergaard, S. D., Larsen, J. T., Petersen, L., Smith, G. D. & Agerbo, E. Psychosocial adversity in infancy and mortality rates in childhood and adolescence: a birth cohort study of 1.5 million individuals. Epidemiology 30, 246–255 (2019).
Ostergaard, S. D. et al. Predicting ADHD by assessment of rutter’s indicators of adversity in infancy. PLoS ONE 11, e0157352 (2016).
VanderWeele, T. J. & Ding, P. Sensitivity analysis in observational research: introducing the E-Value. Ann. Intern. Med. 167, 268–274 (2017).